Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naïve and HSV-2-Infected Subjects

This was a phase I study to assess the safety, tolerability, and immunogenicity of escalating doses of AG-702, a noncovalent complex of an HLA A*0201-restricted epitope in the glycoprotein B protein of herpes simplex virus type 2 (gB2) and truncated human constitutive heat shock protein 70. Similar...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Koelle, David M., Magaret, Amalia, McClurkan, Christopher L., Remington, Michael L., Warren, Terri, Teofilovici, Florentina, Wald, Anna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2008
Konular:
Vaccine Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394846/
https://ncbi.nlm.nih.gov/pubmed/18353920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00020-08
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller